ArticleJournal of glaucoma2026
Patient and Neighborhood Factors Influencing Glaucoma Medication Adherence.
Article in Journal of glaucoma, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
prcisThis study identified patient-level factors as key barriers and facilitators to glaucoma medication adherence, varying by sex and neighborhood disadvantage (ADI), suggesting that targeted interventions could improve glaucoma medication adherence outcomes. PURPOSE: To identify the barriers and facilitators to glaucoma medication adherence for participants in the Support, Educate, Empower Personalized Glaucoma Coaching Program pilot study and assess any differences by demographics. MATERIALS AND
methodsThis was a mixed-methods study of participants who reported glaucoma medication adherence of ≤80.00%. Patient (age, sex, and race) and neighborhood [Area Deprivation Index (ADI)] factors were obtained, and participants completed a semistructured interview. Patient interviews were transcribed and analyzed using the modified Penchansky and Thomas framework to assess barriers and facilitators to glaucoma medication adherence, and participant numbers were computed for each theme.
resultsOf the 44 participants, 52% were 65 years or older, 45% were female, 45.5% were Black, and 34% lived in high-ADI neighborhoods. The most cited theme by participants for barriers and facilitators to medication adherence was patient-level factors (52% and 48%, respectively). Difficulty with the medication schedule was a leading barrier (48%), while the location of eye drops in the home (25%) was a leading facilitator. Patient-level barriers and facilitators differed by sex and ADI.
conclusionPatient-level barriers and facilitators to glaucoma medication adherence were most frequently mentioned. Patient-level facilitators differed by sex and ADI; patient and neighborhood factors should be considered when assessing glaucoma medication adherence, as it may differ by these factors. In this cohort of glaucoma patients with poor medication adherence, patient-level factors served as more significant barriers compared with those related to health care in the US. Consequently, targeted interventions addressing these individual barriers could potentially improve medication adherence outcomes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.